VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Kanjin Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Kanjin Therapeutics is pioneering novel advanced therapeutics to halt and potentially restore kidney function, thus eliminating the need for dialysis.

Also known as Kanjin Therapeutics Inc

  • Biotech & therapeutics
Status
Operatingas of 2026-09-20
Business model
B2B
Legal name
Kanjin Therapeutics Inc
Open relationship map
Claim, correct or request removal

Record updated 29 September 2026

About

Kanjin Therapeutics is a US and Japan based global biotechnology startup with pioneering interventions to restore kidney function and transform the treatment of chronic kidney diseases. Founded as a scientific spinout from Okayama University (Japan), Kanjin unites world-class expertise in kidney biology and translational medicine.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy